Cargando…

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529), first identified in Botswana and South Africa, may compromise vaccine effectiveness and lead to re-infections(1). Here we investigated Omicron escape from neutralization by antibodies from South African individuals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cele, Sandile, Jackson, Laurelle, Khoury, David S., Khan, Khadija, Moyo-Gwete, Thandeka, Tegally, Houriiyah, San, James Emmanuel, Cromer, Deborah, Scheepers, Cathrine, Amoako, Daniel G., Karim, Farina, Bernstein, Mallory, Lustig, Gila, Archary, Derseree, Smith, Muneerah, Ganga, Yashica, Jule, Zesuliwe, Reedoy, Kajal, Hwa, Shi-Hsia, Giandhari, Jennifer, Blackburn, Jonathan M., Gosnell, Bernadett I., Abdool Karim, Salim S., Hanekom, Willem, von Gottberg, Anne, Bhiman, Jinal N., Lessells, Richard J., Moosa, Mahomed-Yunus S., Davenport, Miles P., de Oliveira, Tulio, Moore, Penny L., Sigal, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866126/ https://www.ncbi.nlm.nih.gov/pubmed/35016196 http://dx.doi.org/10.1038/s41586-021-04387-1

Ejemplares similares

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
por: Cele, Sandile, et al.
Publicado: (2021)

SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual
por: Lustig, Gila, et al.
Publicado: (2022)

Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
por: Khan, Khadija, et al.
Publicado: (2021)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Omicron infection enhances Delta antibody immunity in vaccinated persons
por: Khan, Khadija, et al.
Publicado: (2022)

Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
por: Khan, Khadija, et al.
Publicado: (2022)

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
por: Cele, Sandile, et al.
Publicado: (2022)

SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunity
por: Cele, Sandile, et al.
Publicado: (2021)

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists
por: Shey, Muki S., et al.
Publicado: (2016)

Unlocking the efficiency of genomics laboratories with robotic liquid-handling
por: Tegally, Houriiyah, et al.
Publicado: (2020)

HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
por: Karim, Farina, et al.
Publicado: (2021)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model
por: Cromarty, Ross, et al.
Publicado: (2019)

Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model
por: Cromarty, Ross, et al.
Publicado: (2021)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Association Between Human Immunodeficiency Virus Viremia and Compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
por: Hwa, Shi-Hsia, et al.
Publicado: (2022)

Higher mucosal antibody concentrations in women with genital tract inflammation
por: Sobia, Parveen, et al.
Publicado: (2021)

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2013)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage
por: Scheepers, Cathrine, et al.
Publicado: (2022)

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
por: Jackson, Laurelle, et al.
Publicado: (2018)

Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
por: Cromarty, Ross, et al.
Publicado: (2020)

Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward
por: Sobia, Parveen, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq
por: Tshiabuila, Derek, et al.
Publicado: (2022)

Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencing
por: Pillay, Sureshnee, et al.
Publicado: (2023)

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women
por: Mazibuko-Motau, Noluthando, et al.
Publicado: (2022)

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron
por: Keeton, Roanne, et al.
Publicado: (2022)

T cell responses to SARS-CoV-2 spike cross-recognize Omicron
por: Keeton, Roanne, et al.
Publicado: (2022)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
por: Sheward, Daniel J., et al.
Publicado: (2018)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity
por: James, San Emmanuel, et al.
Publicado: (2020)

T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
por: Lustig, Gila, et al.
Publicado: (2021)

A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies
por: Mabvakure, B., et al.
Publicado: (2017)

Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing
por: Singh, Lavanya, et al.
Publicado: (2022)

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
por: Bhiman, Jinal N., et al.
Publicado: (2015)

Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8810vd7pdjnjkhsppgitr20sjh